Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Akbarnejad Z et al. | 2017 | intact cell/cell culture, U87 (human glioblastoma cell line) | magnetic field, signals/pulses, 50/60 Hz | 5–10 mT |
| Akdag MZ et al. | 2010 | animal, rat/Sprague-Dawley, whole body | magnetic field, low frequency, 50/60 Hz | 100–500 µT |
| Akdag MZ et al. | 2013 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz | 100–500 µT |
| Alipour M et al. | 2022 | intact cell/cell culture, rat bone marrow-derived mesenchymal cells (BMSCs) | static magnetic field, magnetic field, 50/60 Hz, co-exposure | - |
| Ambalayam S et al. | 2022 | animal, rat/Wistar | magnetic field, 50/60 Hz, low frequency | - |
| Amiri M et al. | 2018 | intact cell/cell culture, human glioblastoma cell line (U-87) | 50/60 Hz, static magnetic field, magnetic field, co-exposure, also other exposures without EMF | - |
| Aparicio-Bautista DI et al. | 2022 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, low frequency | - |
| Baharara J et al. | 2016 | intact cell/cell culture, A2780 cells (cisplatin-resistant human ovarian adenocarcinoma cells) | magnetic field, 50/60 Hz, co-exposure | 20 mT |
| Basile A et al. | 2011 | intact cell/cell culture, human melanoma cell lines (M14 and A375), animal, mouse/BALB/c nu/nu mic with M14 xenografts, whole body | magnetic field, 50/60 Hz | 30 A/m |
| Benassi B et al. | 2016 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
| Berg H | 2003 | intact cell/cell culture, human myeloid leukemia cell line (K-562) and human non-Hodgkin lymphoma cell line (U-937) | magnetic field, 50/60 Hz, co-exposure | 8–55 mT |
| Berg H et al. | 2003 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) and U937 cells (human leukemic monocyte cell line) and human lymphocytes | magnetic field, 50/60 Hz, co-exposure | 10–35 mT |
| Blumenthal NC et al. | 1997 | intact cell/cell culture, rat tendon fibroblasts and rat bone marrow osteoprogenitor cells (Sprague-Dawley rat) | magnetic field, static magnetic field, intermediate frequency, 50/60 Hz | 0.25–0.5 mT |
| Brisdelli F et al. | 2014 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz, co-exposure | 0.01–2 mT |
| Cecconi S et al. | 2000 | intact cell/cell culture, ovarian follicles from mice (Swiss CD1) | magnetic field, low frequency, signals/pulses, 50/60 Hz | 1.5 mT |
| Cho S et al. | 2014 | intact cell/cell culture, human lymphocytes | magnetic field, 50/60 Hz, co-exposure | 0.8 mT |
| Choi JH et al. | 2022 | intact cell/cell culture, human hair bulb spheroid and hair follicle cultures | magnetic field, 50/60 Hz | - |
| Cios A et al. | 2021 | intact cell/cell culture, HEK293 (kidney cells), 786-O, 769-P, and Caki1 (clear cell renal carcinoma cell lines) | magnetic field, 50/60 Hz | 4.5 mT |
| Consales C et al. | 2019 | - | magnetic field, 50/60 Hz | - |
| Crocetti S et al. | 2013 | intact cell/cell culture, MCF-7 cells (human breast cancer cell line) and MCF-10 cells (human non-tumorigenic breast epithelial cell line) and C2C12 cells (mouse myoblast cell line) | magnetic field, low frequency, signals/pulses, 50/60 Hz | 2–5 mT |
| Ding GR et al. | 2001 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
| Ding GR et al. | 2004 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz | 5 mT |
| Ding Z et al. | 2017 | intact cell/cell culture, B95-8 cells (marmoset lymphocytes), BALB/3T3 cells (embryonal mouse fibroblasts) | 50/60 Hz, magnetic field, co-exposure | 2.3 mT |
| Duan W et al. | 2014 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz | 500 µT |
| Duong CN et al. | 2016 | intact cell/cell culture, HMO6 cells (human microglial cell line) | magnetic field, low frequency, 50/60 Hz, co-exposure | 0.01–1 mT |
| Feng B et al. | 2016 | intact cell/cell culture, human amniotic cells | magnetic field, 50/60 Hz | 0.2–2 mT |
| Garip AI et al. | 2010 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, low frequency, 50/60 Hz | 1 mT |
| Giorgi G et al. | 2014 | intact cell/cell culture, human neuroblastoma cell line (BE(2)C) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
| Grassi C et al. | 2004 | intact cell/cell culture, human neuroblastoma cell line (IMR 32) and rat pituitary (GH3) cell line | magnetic field, low frequency, 50/60 Hz, co-exposure | 200–500 µT |
| Guo H et al. | 2004 | intact cell/cell culture, SNU cells (human gastric adenocarcinoma cell line) | magnetic field, 50/60 Hz | 97 mT |
| Han Q et al. | 2018 | - | magnetic field, 50/60 Hz, co-exposure | - |
| Hisamitsu T et al. | 1997 | intact cell/cell culture, HL-60 and ML-1 cells (human acute myeloid leukaemia cell lines) and human peripheral blood lymphocytes and human peripheral blood polymorphonuclear cells | magnetic field, 50/60 Hz | 45 mT |
| Hosseinabadi MB et al. | 2019 | human | magnetic field, low frequency, 50/60 Hz, occupational | 11.3–18.9 µT |
| Hu Y et al. | 2016 | animal, mouse/3xTg and 129/C57BL/6, whole body | magnetic field, 50/60 Hz | 500 µT |
| Ismael SJ et al. | 1998 | animal, mouse/Swiss, whole body | magnetic field, static magnetic field, 50/60 Hz, DC | 0.4–20 µT |
| Jia HL et al. | 2014 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz, co-exposure | 400 µT |
| Jung JH et al. | 2017 | intact cell/cell culture, human mesenchymal stem cells | magnetic field, low frequency, 50/60 Hz | - |
| Juszczak K et al. | 2012 | intact cell/cell culture, urothelial cells (primary culture from urinary bladders of female Wistar rats) | magnetic field, signals/pulses, 50/60 Hz, electrotherapy | 45 mT |
| Kaszuba-Zwoinska J et al. | 2010 | intact cell/cell culture, U937 (human leukemic monocyte cell line) | magnetic field, signals/pulses, 50/60 Hz, co-exposure | 45 mT |
| Kaszuba-Zwoinska J et al. | 2012 | intact cell/cell culture, Mono Mac 6 cells (human monocytes) | magnetic field, signals/pulses, 50/60 Hz, co-exposure | 45 mT |
| Kayhan H et al. | 2020 | intact cell/cell culture, human, neonatal, healthy primary dermal fibroblast and MCF7 cells (human metastatic breast cancer cells) | magnetic field, 50/60 Hz, low frequency | - |
| Khadir R et al. | 1999 | intact cell/cell culture, neutrophils (from human venous blood) | magnetic field, 50/60 Hz, co-exposure | 0.1–44 mT |
| Kim HS et al. | 2014 | animal, mouse/BALB/c, whole body | magnetic field, 50/60 Hz | 2–200 µT |
| Kim J et al. | 2010 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line) and IMR90 (human lung fibroblasts) | magnetic field, 50/60 Hz | 3–6 mT |
| Kim YW et al. | 2009 | animal, mouse/BALB/c, whole body | magnetic field, 50/60 Hz | 14–200 µT |
| Kiray A et al. | 2013 | animal, rat/Wistar, whole body | magnetic field, 50/60 Hz | 3 mT |
| Koh EK et al. | 2008 | intact cell/cell culture, different human prostate carcinoma cell lines (DU145, LNCaP, PC3) | magnetic field, 50/60 Hz, power transmission line | 0.2–2.5 mT |
| Kroupova J et al. | 2007 | intact cell/cell culture, A549 (human adenocarcinoma cell line) | magnetic field, 50/60 Hz | 2 mT |
| Kumlin T et al. | 2002 | animal, mouse/BALB/CŒDBA/2, whole body | magnetic field, 50/60 Hz, co-exposure | 100 µT |
| Kurian MV et al. | 2012 | intact cell/cell culture, H9c2 cells (myoblast from embryonal rat myocard) | magnetic field, 50/60 Hz, co-exposure | 1–240 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
